Ligand Pharmaceuticals
LGND
#3595
Rank
NZ$6.51 B
Marketcap
NZ$331.25
Share price
0.20%
Change (1 day)
57.70%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.5 Million a decrease over its 2023 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B1061.8%
2024 NZ$9.5 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$28.92 M-97.97%
2019 NZ$1.42 B275.62%
2018 NZ$0.37 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$75.47 M55.41%
2015 NZ$48.56 M36.87%
2014 NZ$35.48 M29.59%
2013 NZ$27.38 M1309.35%
2012 NZ$1.94 M-43.97%
2011 NZ$3.46 M-113.19%
2010 -NZ$26.29 Million59.86%
2009 -NZ$16.45 Million-61.33%
2008 -NZ$42.53 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$85.55 Million81.27%
2005 -NZ$47.2 Million
2003 -NZ$32.86 Million-20.6%
2002 -NZ$41.38 Million4.38%
2001 -NZ$39.64 Million-48.83%
2000 -NZ$77.47 Million-19.74%
1999 -NZ$96.52 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$52.6 Million-5.83%
1996 -NZ$55.86 Million136.23%
1995 -NZ$23.65 Million-33.97%
1994 -NZ$35.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.12 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.97 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$39.55 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.30 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.55 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.76 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.47 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.50 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA